Cargando…
Tolerizing Strategies for the Treatment of Autoimmune Diseases: From ex vivo to in vivo Strategies
Autoimmune diseases such as multiple sclerosis (MS), type I diabetes (T1D), inflammatory bowel diseases (IBD), and rheumatoid arthritis (RA) are chronic, incurable, incapacitating and at times even lethal conditions. Worldwide, millions of people are affected, predominantly women, and their number i...
Autores principales: | Cauwels, Anje, Tavernier, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241419/ https://www.ncbi.nlm.nih.gov/pubmed/32477325 http://dx.doi.org/10.3389/fimmu.2020.00674 |
Ejemplares similares
-
Anti-Inflammatory Effects of Urocanic Acid Derivatives in Models Ex Vivo and In Vivo of Inflammatory Bowel Disease
por: Kammeyer, Arthur, et al.
Publicado: (2012) -
Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation
por: Thome, Aaron D., et al.
Publicado: (2022) -
Redefining Strategies to Introduce Tolerance-Inducing Cellular Therapy in Human beings to Combat Autoimmunity and Transplantation Reactions
por: ten Brinke, Anja, et al.
Publicado: (2014) -
Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
por: Wiesinger, Manuel, et al.
Publicado: (2017) -
CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity
por: Dillinger, Barbara, et al.
Publicado: (2017)